Integrated Biosciences, Inc.

Next week, Max Wilson will be presenting at the Winter Q-Bio Conference, diving into state-of-the-art research in optogenetic engineering of cellular signaling for drug discovery. This annual event brings together leaders and pioneers in quantitative biology, including Nobel laureates Jennifer Doudna and Frances Arnold, among many others. #DrugDiscovery #QuantitativeBiology #Innovation

Great to see our latest paper in Nature Protocols highlighted by the Broad Institute of MIT and Harvard.

One week since our JPM Event, we’re still energized from the fun discussion between Integrated's CEO Felix Wong, Mark DePristo, Thomas Clozel, Huafeng Xu, Robert Marino and Thomas Fuchs on the intersection of data, AI models and therapeutics R&D. A special thanks to Sajith Wickramasekara for an engaging fireside chat with Karen Akinsanya, where she shared her incredible journey into computationally-driven drug discovery. It was a pleasure connecting with so many fantastic people—see you all next year! Wilson Sonsini Goodrich & Rosati, SVB, Illumina Ventures.

Excited to announce that Integrated is hosting a very special cocktail reception at #JPM25! Our ???????? ???? ?????????????? event will delve into the future of computational drug discovery and data-driven innovations, featuring a panel discussion with leading Biotech CEOs, moderated by Eli Lilly and Company’s Chief AI Officer, Thomas Fuchs. We’re also excited to present a Fireside chat with Schr?dinger’s President of R&D Therapeutics,?Karen Akinsanya, moderated by Benchling’s CEO,?Sajith Wickramasekara. It’s a unique opportunity to explore cutting-edge developments shaping the biopharma AI and data landscape. Drop by, if you’re around for JPM. Register:?https://lnkd.in/dwAUnvkJ A huge thank you to our incredible sponsors and speakers for making this possible! Wilson Sonsini Goodrich & Rosati SVB Illumina Ventures Owkin BigHat Biosciences Qubit Pharmaceuticals Atommap

Announcing our latest publication in #Nature Protocols on explainable deep learning for small molecule drug discovery. Our approach guides hypothesis generation and makes searching large chemical spaces more efficient compared with previous methods, which are typically black box in nature and do not generate specific chemical insights. Check it out below: https://lnkd.in/gnUH84-7 #AI #therapeutics

We are thrilled to announce our research collaboration with?LVMH?Recherche. Our partnership brings together the best of artificial intelligence?and?aging biology research to deliver science-backed innovation in consumer skincare and beauty products. Read more here: https://lnkd.in/gFFmW438 #AI?#Aging

We’re #hiring for extraordinary Research Associates, a Head of Chemistry, and a Head of Business Development. For more information, please visit the links below. We look forward to hearing from you! Careers: https://lnkd.in/gm88ec7b Research Associate position: https://lnkd.in/gFRbrZdm Head of Chemistry position: https://lnkd.in/gCEzkkbQ Head of Business Development position: https://lnkd.in/gFrWZzc2

Integrated Biosciences welcomes Illumina Ventures to the family! Our partnership with Illumina Ventures Labs will integrate the company’s drug discovery engine with Illumina sequencing, enabling us to discover and design new classes of small molecule therapeutics that act by shaping the transcriptomes and methylomes of cell populations. These drug candidates will be applicable to diverse diseases for which cell state and identity are important, including diseases related to aging and development. #aging #DNA #RNA #drugdiscovery https://lnkd.in/gFnPQs2b